VIRTUGUIDE System with DePuy Synthes Lapidus Implant for Hallux Valgus
Official title: VIRTUGUIDE™ SYSTEM REGISTRY
Run by DePuy Synthes Products, Inc. · NCT07567092 · Data updated 2026-11-12
This study tests how well the VIRTUGUIDE System with a compatible DePuy Synthes Lapidus implant works for people undergoing a primary Lapidus procedure to correct hallux valgus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | DePuy Synthes Products, Inc. Industry-sponsored |
| Locations | 5 sites (Waterloo, Iowa and 4 other locations) |
| Status | Recruiting |
| Started | July 7, 2026 |
| Main results expected | May 15, 2028 |
| Study ends | May 15, 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07567092 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 or older undergoing a primary Lapidus procedure for hallux valgus who will use the VIRTUGUIDE System with a compatible DePuy Synthes Lapidus implant and can complete translated PROMs.
✕Probably not a fit
Patients not receiving the compatible implant or not undergoing the Lapidus procedure, or unable to complete PROMs, may not derive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates surgeon experience and surgical outcomes when using the VIRTUGUIDE System (software and instruments) together with a compatible DePuy Synthes Lapidus implant during the index Lapidus procedure for hallux valgus. Eligible participants are adults 22 years or older undergoing a primary Lapidus correction and who can complete translated patient-reported outcome measures. The study collects on-label fixation implants and may include data transfer to DePuy Synthes. No interventional treatment beyond standard care is described, and the focus is on real-world performance and outcomes. Participating sites include three midwestern and regional foot and ankle centers in the United States.
Why it matters
Potential benefit: If successful, surgeons may gain insights on the practicality and outcomes of the VIRTUGUIDE System with these implants for hallux valgus correction.
How similar studies have gone: Other studies in adjacent orthopedic procedures have reported practical feasibility and meaningful outcome data with guided instrumentation, but this specific combination is observational and builds on prior selective-use experiences.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Participants, both male and female, \>= 22 years old at the time of consent * Participants undergoing a primary Lapidus procedure for the correction of hallux valgus using the VIRTUGUIDE System (software + instruments) and who receive a compatible DePuy Synthes Lapidus implant * Participants must be able to read and understand questions and responses in an available translated language for patient reported outcomes (PROMs) * All primary Lapidus fixation implants are used on-label according to the implant IFU/FDA cleared labeling * Participants who can speak, read, and comprehend the Institutional Review Board approved Informed Consent Document and are willing and able to provide informed patient consent for participation and have authorized the transfer of his/her information to DePuy Synthes Exclusion criteria: * Participation in any other medical device or medicinal product study within the previous month. Participation in observational studies is allowed * In the opinion of the Principal Investigator, the subject is unable to comply with the requirements of the registry * Participant has known allergies to implant components * Participant presenting for a revision of a Lapidus procedure * Participant has existing hardware in the operative joint
Where it's running
-
MercyOne Waterloo Medical Center
Waterloo, Iowa, United States Recruiting -
The Iowa Clinic
West Des Moines, Iowa, United States Recruiting -
Foot And Ankle Specialists of Southeast Michigan
Warren, Michigan, United States Recruiting -
OrthoCarolina Research Institute
Charlotte, North Carolina, United States Recruiting -
Atlantic Orthopaedic Specialists
Virginia Beach, Virginia, United States Recruiting
Study contacts
- Study coordinator: Marcie Maichle
- Email: MMaichle@ITS.JNJ.com
- Phone: 443-987-0665
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Self-rehabilitation after foot surgery with a connected app
This study tests whether a connected rehabilitation app can help adults after hallux valgus surgery improve ankle and toe mobility at home.
-
Sciatic nerve block with extended-release bupivacaine (ALX006) for bunion surgery
This will test whether a single-dose extended-release bupivacaine (ALX006) given as a sciatic nerve block reduces pain after bunion surgery in adults.
-
One versus two Kirschner wires for minimally invasive correction of severe hallux valgus
This trial tests whether adding a second Kirschner (K-) wire during minimally invasive bunion surgery helps people with severe hallux valgus keep their toe alignment and have fewer complications.
-
Custom 3D-printed toe spacer for bunion (hallux valgus) surgery recovery
This will test whether a custom 3D-printed toe spacer is more comfortable and better at keeping the big toe aligned than a standard folded-gauze spacer for adults after hallux valgus surgery.
-
Examining the relationship between second toe length and hallux valgus in older adults
This study looks at whether the length of the second toe affects the angle of the big toe in older adults with foot X-rays.
-
Using a tourniquet during surgery for bunions
This study tests whether using a tourniquet during bunion surgery helps patients recover better compared to surgery without one.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.